MENU
+Compare
HIMS
Stock ticker: NYSE
AS OF
Oct 17, 04:59 PM (EDT)
Price
$49.77
Change
-$9.38 (-15.86%)
Capitalization
13.37B

HIMS Hims & Hers Health Forecast, Technical & Fundamental Analysis

Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss... Show more

HIMS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for HIMS with price predictions
Oct 16, 2025

HIMS in +0.48% Uptrend, rising for three consecutive days on October 09, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where HIMS advanced for three days, in of 292 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 59 cases where HIMS's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on October 15, 2025. You may want to consider a long position or call options on HIMS as a result. In of 83 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for HIMS just turned positive on October 16, 2025. Looking at past instances where HIMS's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .

HIMS moved above its 50-day moving average on September 18, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for HIMS crossed bullishly above the 50-day moving average on September 18, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 293 cases where HIMS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where HIMS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

HIMS broke above its upper Bollinger Band on October 15, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. HIMS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (23.753) is normal, around the industry mean (17.684). P/E Ratio (74.873) is within average values for comparable stocks, (73.162). Projected Growth (PEG Ratio) (3.898) is also within normal values, averaging (2.099). HIMS has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.030). P/S Ratio (7.241) is also within normal values, averaging (46.659).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
HIMS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

HIMS is expected to report earnings to fall 43.71% to 9 cents per share on November 03

Hims & Hers Health HIMS Stock Earnings Reports
Q3'25
Est.
$0.10
Q2'25
Beat
by $0.02
Q1'25
Missed
by $0.03
Q4'24
Missed
by $0.06
Q3'24
Beat
by $0.22
The last earnings report on August 04 showed earnings per share of 17 cents, beating the estimate of 15 cents. With 38.28M shares outstanding, the current market capitalization sits at 13.37B.
A.I. Advisor
published General Information

General Information

a company, which is involved in real estate investment trusts

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
N/A
Address
2269 Chestnut Street
Phone
+1 415 851-0195
Employees
658
Web
https://www.forhims.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SMDD13.720.49
+3.68%
ProShares UltraPro Short MidCap400
BGM9.380.24
+2.63%
Qilian International Holding Group Ltd
FXB129.200.47
+0.36%
Invesco CcyShrs® British Pound Stlg
PMM6.15N/A
N/A
Putnam Managed Municipal Income
JBBB47.88-0.06
-0.13%
Janus Henderson B-BBB CLO ETF

HIMS and Stocks

Correlation & Price change

A.I.dvisor tells us that HIMS and COTY have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HIMS and COTY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HIMS
1D Price
Change %
HIMS100%
-5.75%
COTY - HIMS
31%
Poorly correlated
-2.12%
EWCZ - HIMS
30%
Poorly correlated
-0.29%
HROW - HIMS
29%
Poorly correlated
-3.85%
ALKS - HIMS
27%
Poorly correlated
-4.44%
ETON - HIMS
25%
Poorly correlated
-4.23%
More

Groups containing HIMS

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HIMS
1D Price
Change %
HIMS100%
-5.75%
Pharmaceuticals: Generic
industry (220 stocks)
40%
Loosely correlated
-0.14%
Pharmaceuticals
industry (384 stocks)
19%
Poorly correlated
-0.19%